Expression of matrix metalloproteinases (MMP.1 and -2) and their inhibitors (TIMP.1, -2 and -3) in oral lichen planus, dysplasia, squamous cell carcinoma and lymph node metastasis
1998

Matrix Metalloproteinases and Their Inhibitors in Oral Cancer

Sample size: 40 publication Evidence: moderate

Author Information

Author(s): M Sutinen, T Kainulainen, T Hurskainen, E Vesterlund, JP Alexander, CM Overall, T Sorsa, T Salo

Primary Institution: University of Oulu, Finland

Hypothesis

The study investigates the expression and distribution of MMP-1, MMP-2, and their inhibitors in various oral lesions.

Conclusion

The study found that MMPs and TIMPs are up-regulated during invasion in oral squamous cell carcinoma, while their expression is low in premalignant lesions.

Supporting Evidence

  • MMP-1 mRNA was detected in fibroblastic cells of tumoral stroma in oral SCC.
  • MMP-2 mRNA expression was noted in fibroblasts surrounding carcinoma cells.
  • TIMP-3 mRNA expression was seen in stromal cells surrounding neoplastic islands in all SCCs studied.
  • Expression of MMPs and TIMPs was consistently low in oral epithelial dysplasias and normal mucosa.
  • Elevated levels of MMP-2 and MMP-9 were observed in carcinoma samples compared to lichen planus or normal oral mucosa.

Takeaway

This study looked at how certain proteins related to cancer are found in different mouth conditions, showing that they are more active in cancer than in less serious conditions.

Methodology

The study used in situ hybridization, immunohistochemistry, and zymography to analyze tissue samples from various oral lesions.

Limitations

The study did not explore the long-term implications of MMP and TIMP expression in cancer progression.

Participant Demographics

The study included samples from patients with oral squamous cell carcinoma, lymph node metastases, lichen planus, epithelial dysplasias, and normal buccal mucosa.

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication